# Revocation of Regulation on Positron Emission Tomography Drug Products
> **Food and Drug Administration** · Final rule; revocation. · Published 1997-12-19 · Effective 1997-12-21 · 62 FR 66522
## Document
- **Document number:** 97-33187
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 62 FR 66522
- **CFR reference:** 21 CFR 211
- **Publication date:** 1997-12-19
- **Effective date:** 1997-12-21
- **HHS docket:** Docket No. 94N-0421
## Abstract

The Food and Drug Administration (FDA) is revoking a regulation on positron emission tomography (PET) radiopharmaceutical drug products. The regulation permits FDA to approve requests from manufacturers of PET drugs for exceptions or alternatives to provisions of the current good manufacturing practice (CGMP) regulations. FDA is taking this action in accordance with provisions of the Food and Drug Administration Modernization Act of 1997 (Modernization Act). Elsewhere in this issue of the Federal Register, FDA is publishing a notice revoking two notices concerning certain guidance documents on PET drugs and the guidance documents to which the notices relate.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/1997/12/19/97-33187/revocation-of-regulation-on-positron-emission-tomography-drug-products)
---
*AI Analytics · CC0 1.0*